1. Home
  2. IH vs GOSS Comparison

IH vs GOSS Comparison

Compare IH & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.68

Market Cap

82.8M

Sector

Real Estate

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$0.33

Market Cap

88.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
GOSS
Founded
1996
2015
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
82.8M
88.6M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
IH
GOSS
Price
$1.68
$0.33
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$4.19
AVG Volume (30 Days)
8.4K
5.0M
Earning Date
03-31-2026
05-07-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,471,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$201.64
P/E Ratio
$7.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$0.32
52 Week High
$3.60
$3.87

Technical Indicators

Market Signals
Indicator
IH
GOSS
Relative Strength Index (RSI) 44.86 33.20
Support Level $1.55 N/A
Resistance Level $1.83 $0.47
Average True Range (ATR) 0.08 0.03
MACD -0.00 0.01
Stochastic Oscillator 21.43 16.03

Price Performance

Historical Comparison
IH
GOSS

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Share on Social Networks: